The stocks making the biggest moves in premarket trading include Novavax, Regeneron, Square, Nvidia, and more.
from "Operation Warp Speed," the government program aimed at speeding the development and delivery of a Covid-19 vaccine.
The money will be used to complete late-stage studies, establish large-scale manufacturing, and deliver 100 million doses as early as late 2020. – The drugmaker was also the recipient of "Operation Warp Speed" funding, receiving $450 million for the development and production of its Covid-19 anti-viral antibody cocktail. The company said initial doses could be ready as soon as the end of the summer.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Stocks making the biggest moves midday: Uber, Spotify, Tesla, Dominion Energy, Zoom Video & moreUber shares get a boost on news of a deal with Postmates. Spotify falls on an analyst downgrade.
Lire la suite »
Stocks making the biggest moves after hours: Tesla, Red Rock Resorts, Fitbit and moreSee which stocks are posting big moves after the bell.
Lire la suite »
Regeneron Advances Covid-19 Drug Into Later-Stage TestingRegeneron Pharmaceuticals said it is starting later-stage studies of its experimental Covid-19 drug, a quick move into testing that could establish whether it can be used for treatment and prevention
Lire la suite »
U.S. government awards Novavax $1.6 billion for coronavirus vaccineThe U.S. government has awarded Novavax Inc $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021. Novavax shares jumped 35% in premarket trade. The award is the biggest
Lire la suite »
U.S. government awards Novavax $1.6 billion for coronavirus vaccineThe U.S. government has awarded Novavax Inc $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021.
Lire la suite »
Regeneron begins coronavirus antibody cocktail late-stage trialRegeneron Pharmaceuticals said on Monday it began late-stage clinical trials to assess the effectiveness of its antibody cocktail in preventing and treating Covid-19.
Lire la suite »